{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Predictive Oncology Hires Investor Relations Firm - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"jYZP69wVzG\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/predictive-oncology-hires-investor-relations-firm\/\">Predictive Oncology Hires Investor Relations Firm<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/predictive-oncology-hires-investor-relations-firm\/embed\/#?secret=jYZP69wVzG\" width=\"600\" height=\"338\" title=\"&#8220;Predictive Oncology Hires Investor Relations Firm&#8221; &#8212; Market Newsdesk\" data-secret=\"jYZP69wVzG\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) &#8212; Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (\u201cAI\u201d) to personalized medicine and drug discovery, is pleased to announce that it has engaged Landon Capital to provide investor relations services\u00a0effective\u00a0December 30, 2020. \u00a0Services will include introductions to investors, financial and industry analysts, registered brokers and financial writers with a view to informing such groups about developments in the Company\u2019s business and affairs. Landon Capital will assist to develop a database of individuals, financial institutions or other\u00a0persons potentially interested in receiving publicly available information relating to the Company and making efforts to efficiently provide such information. About Predictive Oncology Inc. Predictive Oncology (NASDAQ: POAI) operates through three segments (Skyline, Helomics &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDMxMSMzOTAzNzg0IzIwMTkyMjY="}